Uganda Launches first clinical trial of chemotherapeutic products to treat Covid-19.Since March 2020, Uganda has been battling COVID-19. There are 39,188 confirmed COVID-19 cases, with 433 active cases and 318 deaths. The Presidential Scientific Initiative on Epidemics (PRESIDE) together with NCRI  has launched the first clinical trial of natural chemotherapeutic products to treat viral and bacterial infections.The product code is UBV-01N. According to the initiative, it is the first Ugandan natural chemotherapeutic product to go through an international level clinical trial process.

The trial will analyse and validate a natural product anticipated to have antiviral, anti-inflammatory and immunological ability.
The clinical trial will validate the content, standardization and replication of the product after which it will be rolled out for industrial production and wide spread use. The product has already gone through multiple quality assurance steps and got all necessary certifications and approval for use in human beings in a clinical trial setting. A highly competent team in Mulago Hospital will conduct the trial

Your email address will not be published. Required fields are marked *

*

COVID-19 - Hope is here by NCRI

A CLINICAL EVALUATION OF EFFICACY, SAFETY IMMUNOGENICITY AND RELIABILITY OF UBV-01N- A NOVAL NATURAL PRODUCT- IN ADULT PATIENTS INFECTED WITH SARS-COV-2 (COVID-19), IN UGANDA